Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Maintenance Studies.
about
Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Maintenance Studies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Pharmacokinetics and Exposure- ...... ction and Maintenance Studies.
@en
Pharmacokinetics and Exposure- ...... ction and Maintenance Studies.
@nl
type
label
Pharmacokinetics and Exposure- ...... ction and Maintenance Studies.
@en
Pharmacokinetics and Exposure- ...... ction and Maintenance Studies.
@nl
prefLabel
Pharmacokinetics and Exposure- ...... ction and Maintenance Studies.
@en
Pharmacokinetics and Exposure- ...... ction and Maintenance Studies.
@nl
P2860
P356
P1476
Pharmacokinetics and Exposure- ...... ction and Maintenance Studies.
@en
P2093
P2860
P356
10.1093/ECCO-JCC/JJW141
P577
2016-07-31T00:00:00Z